Burcon Signs LOI with Major CPG Customer for Sales of Up to US$6 Million in 2027
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Burcon NutraScience (BRCNF) signed a non-binding letter of intent to supply protein ingredients to an existing consumer packaged goods customer. The proposed expansion could generate up to US$6 million in sales in calendar 2027, based on the customer's anticipated needs. The parties are still negotiating a definitive supply agreement.
The proposed sales carry no guaranteed minimum purchase commitment and depend on signing the definitive agreement, production schedules and other commercial conditions. Burcon expects the anticipated purchase volumes, if realized, to increase its commercial revenue and support its plans to scale production in 2027. The company is working to improve its manufacturing capabilities and operating reliability to meet anticipated demand.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate point. Forward-looking: it has not happened yet and may not happen.Proposed expansion with an existing customer could generate up to US$6 million in protein ingredient sales in calendar 2027 80% of market cap
- Minor point. Forward-looking: it has not happened yet and may not happen.Production scale-up is planned for 2027, with work underway to improve manufacturing capabilities and operating reliability
Negative
- Moderate pointLetter of intent is non-binding, and a definitive supply agreement is still under negotiation
- Minor pointProposed sales carry no guaranteed minimum purchase commitment
- Minor point. Forward-looking: it has not happened yet and may not happen.Production schedules and other commercial conditions still affect whether the anticipated sales materialize
AI-generated analysis. How Rhea-AI works. Not financial advice.
Proposed supply agreement represents a significant step in Burcon's commercial expansion and provides greater visibility into 2027 revenue growth
Vancouver, British Columbia--(Newsfile Corp. - November 19, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, today announced that it has signed a non-binding letter of intent ("LOI") with an established consumer packaged goods ("CPG") company and existing customer for the supply of up to US
The proposed agreement represents a significant expansion of an existing customer relationship and reflects growing commercial adoption of Burcon's protein ingredients. If realized, the anticipated purchase volumes will represent a meaningful increase in Burcon's commercial revenue and support its plans to scale production in 2027.
"We are seeing commercial adoption accelerate as customers move from initial product validation to increasingly significant commercial opportunities," said Kip Underwood, Chief Executive Officer. "This LOI reflects the growing value our differentiated protein technology delivers to mainstream food and beverage companies. The potential scale of this expanded customer relationship reinforces our confidence in our 2027 growth objectives and the opportunity beyond."
The potential US
Burcon continues to advance its manufacturing capabilities and operational reliability to support anticipated customer demand. The Company remains focused on commercial execution, expanding customer adoption, and scaling production to capture the growing opportunity for specialty plant-based protein ingredients.
About Burcon NutraScience Corporation
Burcon is a global technology leader in plant-based proteins for food and beverage applications. The Company has developed a portfolio of high-performance protein ingredients, including Peazzaz® pea proteins, FavaPro® fava proteins and Puratein® canola proteins, and is focused on commercializing its technologies through manufacturing partnerships and growing customer adoption worldwide. http://www.burcon.ca/
Forward-Looking Information Cautionary Statement
The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements or forward-looking information can be identified by words such as "anticipate," "aim", "intend," "plan," "goal," "project," "estimate," "expect," "believe," "future," "likely," "may," "should," "could," "will" and similar references to future periods. All statements included in this release, other than statements of historical fact, are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements or information. Forward looking statements in this press release include, among others, the ability of Burcon to negotiate the terms of a definitive supply agreement, the ability of Burcon to meet customer demand for its products, the expected sales under the supply agreement, and the achievement of positive cash flows in 2027. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the implementation of our business model and growth strategies; trends and competition in our industry our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations, and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form for the year ended March 31, 2026 and its other public filings with Canadian securities regulators on SEDAR+ at www.sedarplus.ca. This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements or information. Any forward-looking statement or information speaks only as of the date on which it was made, and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.
Industry and Investor Contact
Investor Relations and Communications
Burcon NutraScience Corporation
720 - 999 West Broadway, Vancouver, BC, V5Z 1K5
Tel (604) 733-0896
info@burcon.ca www.burcon.ca
Media Contact:
Steve Campbell, APR
President
Campbell & Company Public Relations
Tel (604) 888-5267
TECH@CCOM-PR.COM

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/324870
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.